Computerised Testing of Cognitive Response to Cerebrospinal Fluid Shunting in Idiopathic Normal Pressure Hydrocephalus

Sponsor
Umeå University (Other)
Overall Status
Unknown status
CT.gov ID
NCT01618500
Collaborator
(none)
80
4
14
20
1.4

Study Details

Study Description

Brief Summary

A novel computerised neuropsychological test battery for normal pressure hydrocephalus (NPH) has been developed. The aim is to provide the clinician with a free of charge, standardized tool, assessing the cognitive decline or improvements in the cognitive domains specific for NPH. Results from the battery indicate good reliability and validity for the computerized tests

Results from the computerised battery seems promising. However, ability for the battery to detect cognitive improvements after a shunt operation remains to be tested.

Study objectives

  1. Improvement after shunt. The aim of this study is to evaluate the effects of shunting on neuropsychological performance in NPH patients, using a computerized battery.

  2. Feasibility. The ability to complete the test battery by the intended patient group will be tested.

  3. Baseline profile. Baseline scores for NPH-patients will be compared to scores of healthy individuals (from previous study).

Condition or Disease Intervention/Treatment Phase

    Study Design

    Study Type:
    Observational
    Anticipated Enrollment :
    80 participants
    Observational Model:
    Cohort
    Time Perspective:
    Prospective
    Official Title:
    Computerised Testing of Cognitive Response to Cerebrospinal Fluid Shunting in Idiopathic Normal Pressure Hydrocephalus
    Study Start Date :
    Jan 1, 2012
    Anticipated Primary Completion Date :
    Mar 1, 2013
    Anticipated Study Completion Date :
    Mar 1, 2013

    Arms and Interventions

    Arm Intervention/Treatment
    INPH-patients

    Inclusion criteria Older than 60 years of age "Probable INPH" according to the NIH guidelines Planned shunt surgery based on a diagnosis of INPH. Exclusion criteria Known cause for hydrocephalus (i.e., secondary NPH). Medical condition preventing cognitive testing (e.g. deafness, blindness). Patients not considered for shunt operation.

    Outcome Measures

    Primary Outcome Measures

    1. Neuropsychological outcome [4.5 ± 1.5 months]

      INPH patients, who are shunt candidates, will complete a computerized battery at two occasions: (1) hospital admission (Baseline) at most 1 month prior to surgery, and (2) 4.5 ± 1.5 months after shunt operation (Post-Shunt).

    Secondary Outcome Measures

    1. Mini mental state Examination [4.5 ± 1.5 months]

      INPH patients, who are shunt candidates, at each center will complete the Mini Mental State Examination at: (1) hospital admission (Baseline) at most 1 month prior to surgery, and (2) 4.5 ± 1.5 months after shunt operation (Post-Shunt).

    2. Feasibility [4.5 ± 1.5 months]

      The number of patients who are able to complete individual subtests and the entire battery, will be monitored.

    3. Baseline cognitive profile compared to healthy []

      The baseline cognitive profile of INPH-patients will be compared to healthy individuals (from previous study).

    Eligibility Criteria

    Criteria

    Ages Eligible for Study:
    60 Years and Older
    Sexes Eligible for Study:
    All
    Accepts Healthy Volunteers:
    No
    Inclusion Criteria:
    • Older than 60 years of age

    "Probable INPH" according to the NIH guidelines

    Planned shunt surgery based on a diagnosis of INPH.

    Exclusion Criteria:
    • Known cause for hydrocephalus (i.e., secondary NPH). Medical condition preventing cognitive testing (e.g. deafness, blindness).

    Patients not considered for shunt operation.

    Contacts and Locations

    Locations

    Site City State Country Postal Code
    1 Ålborg University Hospital Ålborg Denmark 9100
    2 Linköping University Hospital Linköping Sweden 581 85
    3 Umeå University Umeå Sweden 901 85
    4 Akademiska sjukhuset Uppsala Sweden 751 85

    Sponsors and Collaborators

    • Umeå University

    Investigators

    None specified.

    Study Documents (Full-Text)

    None provided.

    More Information

    Publications

    None provided.
    Responsible Party:
    Anders Behrens, M.D., M.Sc., Umeå University
    ClinicalTrials.gov Identifier:
    NCT01618500
    Other Study ID Numbers:
    • 2011-47-31M
    First Posted:
    Jun 13, 2012
    Last Update Posted:
    Jun 13, 2012
    Last Verified:
    Jun 1, 2012

    Study Results

    No Results Posted as of Jun 13, 2012